Fabentech
Develops antibody-based emergency treatments for governments and health organizations facing biological threats
Highlights
- New on EvolcAdded 2026-10-30
About Fabentech
Fabentech develops and produces polyclonal antibody treatments to counter biological threats, including toxins and emerging infectious diseases. Its FabShield platform uses purified antibody fragments to neutralize viruses and toxins.
The company works with governments and health organizations, providing medical countermeasures for public-health emergencies and biodefence. Its pipeline includes programs for ricin, H5N1, Nipah and sarbecoviruses.
Fabentech is headquartered in Lyon, France, and was founded in 2009. It develops and produces treatments for pandemic preparedness and bioterrorism response.
Product: Develops and produces polyclonal antibody treatments and medical countermeasures for biological threats.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in Finland, worth €2.8M as awarded. From EU award notices (TED) that name Fabentech by its registry number.
- 7 Aug 2025 Terveyden ja hyvinvoinnin laitos · Risiinitoksiinin polyklonaalinen vasta-aine · €2.8M notice
Jobs at Fabentech
More biotech & pharma companies
Fermentalg
Microalgae-derived ingredients for nutrition, wellness and pet health companiesNew on EvolcGenclis
Biotechnology company developing RNA-derived therapeutics for drug discovery and developmentNew on EvolcGenerare Bioscience
Microbial chemistry libraries and screenable molecules for pharma and biotech drug discovery programsNew on EvolcRemote-friendlyGENOMINES
Grows nickel-accumulating plants on low-grade soils to produce battery-grade nickel for critical metal supply chainsGenoscreen
Genomics, sequencing and bioinformatics services for academic and industrial research teamsNew on EvolcGenoskin
Ex vivo human skin models, mast cells and research services for pharmaceutical, biotech, cosmetics and medical-device developersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Google Tag Manager
- Google reCAPTCHA
- PHP
- WordPress